Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    18422971 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting T- XELOX in HER2-positive Stage III Gastric Cancer After D2 Gastrectomy
Condition: Gastric Cancer
Interventions: Drug: Trastuzumab;   Drug: Capecitabine;   Drug: Oxaliplatin
2 Active, not recruiting Trastuzumab in Combination With Capecitabine and Oxaliplatin(XELOX) in Patients With Advanced Gastric Cancer(AGC)
Conditions: Metastatic or Recurrent Gastric Adenocarcinoma;   Her-2 Positive Gastric Cancer
Intervention: Drug: Herceptin+XELOX

Study has passed its completion date and status has not been verified in more than two years.